Steven Glazer
Direttore Tecnico/Scientifico/R&S presso Glazer Consulting Holding ApS
Profilo
Steven Glazer is currently the Chief Medical Officer at MonTa Biosciences ApS, Allero Therapeutics BV, and Glazer Consulting Holding ApS.
Previously, he worked as the Medical Director at Novo Nordisk Scandinavia AB, Independent Director at Mendus AB, Medical Director at RhoVac AB, Senior Vice President-Development at BioInvent International AB, Vice President-Development at Zealand Pharma A, Chief Medical Officer & Vice President at Hansa Biopharma AB, Chief Marketing Officer at Idogen AB, and Chief Medical Officer at Ectin Research AB.
He holds a doctorate degree from the University of Copenhagen.
Posizioni attive di Steven Glazer
| Società | Posizione | Inizio |
|---|---|---|
| Glazer Consulting Holding ApS | Direttore Tecnico/Scientifico/R&S | - |
MonTa Biosciences ApS
 MonTa Biosciences ApS BiotechnologyHealth Technology MonTa Biosciences ApS engages in research and development in biotechnology for cancer immunotherapy. Its technology offers a solution to deliver immune stimulating compounds directly to immune cells in the blood. The company was founded by Thomas Lars Andresen, Jonas Henriksen, and Simon Skjøde Jensen in August 2014 and is headquartered in Brønshøj, Denmark. | Direttore Tecnico/Scientifico/R&S | - |
Allero Therapeutics BV
 Allero Therapeutics BV Miscellaneous Commercial ServicesCommercial Services Allero Therapeutics BV is a biopharmaceutical company, which engages in the development of immunotherapies. It focuses on the research and development pipeline with a focus on a celiac disease product and a food allergy product. The company was founded by Poul Sorensen, Emil Pot, Federico Grego, and Kees Leenhouts and is headquartered in Rotterdam, the Netherlands. | Direttore Tecnico/Scientifico/R&S | - |
Precedenti posizioni note di Steven Glazer
| Società | Posizione | Fine |
|---|---|---|
| CHOSA ONCOLOGY AB | Corporate Officer/Principal | - |
| IDOGEN AB (PUBL) | Vendite & Marketing | - |
| ECTIN RESEARCH AB | Direttore Tecnico/Scientifico/R&S | - |
Novo Nordisk Scandinavia AB
 Novo Nordisk Scandinavia AB Pharmaceuticals: MajorHealth Technology Novo Nordisk Scandinavia AB develops, manufactures and markets pharmaceutical products and services. Its products include medicine for diabetes, hemophilia, growth disorders, and hormone therapy. The company is headquartered in Malmö, Sweden. | Direttore Tecnico/Scientifico/R&S | - |
| ZEALAND PHARMA A/S | Corporate Officer/Principal | - |
Formazione di Steven Glazer
| University of Copenhagen | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 6 |
|---|---|
| BIOINVENT INTERNATIONAL AB | Health Technology |
| ZEALAND PHARMA A/S | Health Technology |
| HANSA BIOPHARMA AB | Health Technology |
| MENDUS AB | Health Technology |
| IDOGEN AB (PUBL) | Health Technology |
| ECTIN RESEARCH AB | Health Technology |
| Aziende private | 5 |
|---|---|
Novo Nordisk Scandinavia AB
Novo Nordisk Scandinavia AB Pharmaceuticals: MajorHealth Technology Novo Nordisk Scandinavia AB develops, manufactures and markets pharmaceutical products and services. Its products include medicine for diabetes, hemophilia, growth disorders, and hormone therapy. The company is headquartered in Malmö, Sweden. | Health Technology |
RhoVac AB
 RhoVac AB BiotechnologyHealth Technology RhoVac AB opertaes as biotechnology company that engages in the research and development of immunotherapy. The firm develops therapeutic cancer vaccines. Its main focus is the development of a drug with the potential to prevent or limit the metastasis of metastatic cancers. The company was founded by Bo Anders Ljungqvist, Per Thor Straten, and Mads Hald Andersen in November 2015 and is headquartered in Lund, Sweden. | Health Technology |
MonTa Biosciences ApS
MonTa Biosciences ApS BiotechnologyHealth Technology MonTa Biosciences ApS engages in research and development in biotechnology for cancer immunotherapy. Its technology offers a solution to deliver immune stimulating compounds directly to immune cells in the blood. The company was founded by Thomas Lars Andresen, Jonas Henriksen, and Simon Skjøde Jensen in August 2014 and is headquartered in Brønshøj, Denmark. | Health Technology |
Allero Therapeutics BV
Allero Therapeutics BV Miscellaneous Commercial ServicesCommercial Services Allero Therapeutics BV is a biopharmaceutical company, which engages in the development of immunotherapies. It focuses on the research and development pipeline with a focus on a celiac disease product and a food allergy product. The company was founded by Poul Sorensen, Emil Pot, Federico Grego, and Kees Leenhouts and is headquartered in Rotterdam, the Netherlands. | Commercial Services |
| Glazer Consulting Holding ApS |
- Borsa valori
- Insiders
- Steven Glazer
